CompletedNot Applicable

Effects of Pilates and Neuromuscular Exercises on Postural Control in Dynamic Knee Valgus

Turkey (Türkiye)36 participantsStarted 2024-06-01

Plain-language summary

This randomized controlled trial aims to investigate the effects of neuromuscular and Pilates exercise programs compared with a control group in young adults with dynamic knee valgus (DKV). Thirty-six participants were randomly assigned to neuromuscular, Pilates, or control groups. The intervention groups completed a supervised exercise program three times per week for six weeks (18 sessions). The primary outcome is the frontal plane projection angle (FPPA) during single-leg tasks. Secondary outcomes include muscle strength, balance, and vertical jump performance.

Who can participate

Age range

18 Years – 24 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * having asymptomatic dynamic knee valgus * being between 18 and 24 years of age * having no medical history, a body mass index (BMI) between 18 and 24 * no history of orthopedic, neurological, vascular, systemic, or rheumatic diseases * no complaints of pain in any part of the body during physical activities * the ability to communicate in Turkish (both written and verbal) Exclusion Criteria: * individuals with hip anteversion or retroversion or other postural disorders affecting knee kinematics, those unable to perform the exercises as demonstrated, those experiencing pain during exercises (VAS \>5) * individuals with a history of orthopedic surgery, those with strength deficits between extremities * the presence of cognitive or psychological disorders that could hinder cooperation * pregnancy or suspected pregnancy * sleep disorders, regular medication use, intake of painkillers, sedatives, or psychiatric drugs within the last 24 hours * history of chronic systemic, rheumatologic, neurological, or vascular diseases

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Frontal Plane Projection Angle (FPPA)

Timeframe: At baseline (Day 1) and following completion of 6 weeks of intervention (Week 6)

Trial details

NCT IDNCT07192796

SponsorŞebnem Nur Alkan

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-08-20

View on ClinicalTrials.gov More Dynamic Knee Valgus trials